BioSpace News Archive

Immunic, Inc. announced management’s participation in the following industry and investor conferences in November

Boston Scientific Corporation announced that, pursuant to the previously announced cash tender offer for up to $1.0 billion aggregate principal amount of the outstanding senior notes listed in the table below, approximately $1.6 billion in aggregate principal amount of the Securities were validly tendered and not validly withdrawn on or prior to 5:00 p.m., Eastern Standard Time (EST), on November 4, 2019.

Regeneron Pharmaceuticals, Inc. announced financial results for the third quarter of 2019 and provided a business update..

Regeneron Pharmaceuticals, Inc. provided an update on the ongoing Phase 3 development program evaluating Libtayo®, a PD-1 inhibitor, as monotherapy and combination therapy in first-line patients with advanced non-small cell lung cancer Regeneron is currently recruiting patients in two Phase 3 trials in first-line NSCLC.

Genetic Technologies Limited, a diversified molecular diagnostics company, announced an update to shareholders on recent achievements and upcoming milestones.

Dr. Howard Mayer, Executive Vice-President and Head of Research and Development, effective December 1st, 2019

Start-up companies ImagoWorks and Sibel recognized for novel health tech solutions that harness artificial intelligence, geometrical modeling and bio-integrated sensors aiming to improve the detection, prevention and and treatment of diseases

New data from Juniper Research has shown that the total value of B2B cross-border payments immutably stored on blockchain will exceed $4.4 trillion by 2024; up from $171 billion in 2019.

Net sales amounted to 282.7 MSEK (232.2), which is an increase by 21.7 percent compared to the corresponding quarter last year. At comparable exchange rates and adjusted for acqusitions) sales increased by 8.1 percent.

Integration of PAA’s S-LAB with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development